• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Dashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlerts
    Company
    AboutQuantisnow PlusContactJobs
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed by AEGON N.V. (Amendment)

    2/1/23 4:54:05 PM ET
    $AEG
    Life Insurance
    Finance
    Get the next $AEG alert in real time by email
    SC 13G/A 1 nl0000303709_020123.txt nl0000303709_020123.txt SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No: 3) AEGON NV -------------------------------------------------------- (Name of Issuer) Common Stock -------------------------------------------------------- (Title of Class of Securities) B0338S9 -------------------------------------------------------- (SEDOL Number) December 31, 2022 -------------------------------------------------------- (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). SEDOL No. B0338S9 (1)Names of reporting persons. BlackRock, Inc. (2) Check the appropriate box if a member of a group (a) [ ] (b) [X] (3) SEC use only (4) Citizenship or place of organization Delaware Number of shares beneficially owned by each reporting person with: (5) Sole voting power 104668168 (6) Shared voting power 0 (7) Sole dispositive power 114047254 (8) Shared dispositive power 0 (9) Aggregate amount beneficially owned by each reporting person 114047254 (10) Check if the aggregate amount in Row (9) excludes certain shares (11) Percent of class represented by amount in Row 9 5.4% (12) Type of reporting person HC Item 1. Item 1(a) Name of issuer: ----------------------------------------------------------------------- AEGON NV Item 1(b) Address of issuer's principal executive offices: ----------------------------------------------------------------------- AEGONPLEIN 50 THE HAGUE Netherlands 2591 TV Item 2. 2(a) Name of person filing: ---------------------------------------------------------------------- BlackRock, Inc. 2(b) Address or principal business office or, if none, residence: ----------------------------------------------------------------------- BlackRock, Inc. 55 East 52nd Street New York, NY 10055 2(c) Citizenship: -------------------------------------------------------------------- See Item 4 of Cover Page 2(d) Title of class of securities: ------------------------------------------------------------------- Common Stock 2(e) SEDOL No.: See Cover Page Item 3. If this statement is filed pursuant to Rules 13d-1(b), or 13d-2(b) or (c), check whether the person filing is a: [ ] Broker or dealer registered under Section 15 of the Act; [ ] Bank as defined in Section 3(a)(6) of the Act; [ ] Insurance company as defined in Section 3(a)(19) of the Act; [ ] Investment company registered under Section 8 of the Investment Company Act of 1940; [ ] An investment adviser in accordance with Rule 13d-1(b)(1)(ii)(E); [ ] An employee benefit plan or endowment fund in accordance with Rule 13d-1(b)(1)(ii)(F); [X] A parent holding company or control person in accordance with Rule 13d-1(b)(1)(ii)(G); [ ] A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813); [ ] A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940; [ ] A non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J); [ ] Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K). If filing as a non-U.S. institution in accordance with Rule 240.13d-1(b)(1)(ii)(J), please specify the type of institution: Item 4. Ownership Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified in Item 1. Amount beneficially owned: 114047254 Percent of class 5.4% Number of shares as to which such person has: Sole power to vote or to direct the vote 104668168 Shared power to vote or to direct the vote 0 Sole power to dispose or to direct the disposition of 114047254 Shared power to dispose or to direct the disposition of 0 Item 5. Ownership of 5 Percent or Less of a Class. If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following [ ]. Item 6. Ownership of More than 5 Percent on Behalf of Another Person If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required. Various persons have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of the common stock of AEGON NV. No one person's interest in the common stock of AEGON NV is more than five percent of the total outstanding common shares. Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person. See Exhibit A Item 8. Identification and Classification of Members of the Group If a group has filed this schedule pursuant to Rule 13d-1(b)(ii)(J), so indicate under Item 3(j) and attach an exhibit stating the identity and Item 3 classification of each member of the group. If a group has filed this schedule pursuant to Rule 13d-1(c) or Rule 13d-1(d), attach an exhibit stating the identity of each member of the group. Item 9. Notice of Dissolution of Group Notice of dissolution of a group may be furnished as an exhibit stating the date of the dissolution and that all further filings with respect to transactions in the security reported on will be filed, if required, by members of the group, in their individual capacity. See Item 5. Item 10. Certifications By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. Dated: February 1, 2023 BlackRock, Inc. Signature: Spencer Fleming ------------------------------------------- Name/Title Attorney-In-Fact The original statement shall be signed by each person on whose behalf the statement is filed or his authorized representative. If the statement is signed on behalf of a person by his authorized representative other than an executive officer or general partner of the filing person, evidence of the representative's authority to sign on behalf of such person shall be filed with the statement, provided, however, that a power of attorney for this purpose which is already on file with the Commission may be incorporated by reference. The name and any title of each person who signs the statement shall be typed or printed beneath his signature. Attention: Intentional misstatements or omissions of fact constitute Federal criminal violations (see 18 U.S.C. 1001). Exhibit A Subsidiary BlackRock Life Limited Aperio Group, LLC BlackRock Advisors, LLC BlackRock (Netherlands) B.V. BlackRock Institutional Trust Company, National Association BlackRock Asset Management Ireland Limited BlackRock Financial Management, Inc. iShares (DE) I Investmentaktiengesellschaft mit Teilgesellsc BlackRock Japan Co., Ltd. BlackRock Asset Management Schweiz AG BlackRock Investment Management, LLC BlackRock Investment Management (UK) Limited BlackRock Asset Management Canada Limited BlackRock Asset Management Deutschland AG BlackRock (Luxembourg) S.A. BlackRock Investment Management (Australia) Limited BlackRock Advisors (UK) Limited BlackRock Fund Advisors BlackRock Asset Management North Asia Limited BlackRock (Singapore) Limited BlackRock Fund Managers Ltd *Entity beneficially owns 5% or greater of the outstanding shares of the security class being reported on this Schedule 13G. Exhibit B POWER OF ATTORNEY The undersigned, BLACKROCK, INC., a corporation duly organized under the laws of the State of Delaware, United States (the "Company"), does hereby make, constitute and appoint each of Christopher Meade, Daniel Waltcher, Una Neary, Richard Cundiff, Charles Park, Enda McMahon, Arlene Klein, Con Tzatzakis, Karen Clark, David Maryles, Daniel Ronnen, John Stelley, Daniel Riemer, Elizabeth Kogut, Maureen Gleeson, Daniel Kalish and Spencer Fleming acting severally, as its true and lawful attorneys-in-fact, for the purpose of, from time to time, executing in its name and on its behalf, whether the Company individually or as representative of others, any and all documents, is acting certificates, instruments, statements, other filings and amendments to the foregoing (collectively, "documents") determined by such person to be necessary or appropriate to comply with ownership or control-person reporting requirements imposed by any United States or non-United States governmental or regulatory authority, Including without limitation Forms 3, 4, 5, 13D, 13F, 13G and 13H and any amendments to any of the Foregoing as may be required to be filed with the Securities and Exchange Commission, and delivering, furnishing or filing any such documents with the appropriate governmental, regulatory authority or other person, and giving and granting to each such attorney-in-fact power and authority to act in the premises as fully and to all intents and purposes as the Company might or could do if personally present by one of its authorized signatories, hereby ratifying and confirming all that said attorney-in-fact shall lawfully do or cause to be done by virtue hereof. Any such determination by an attorney-in-fact named herein shall be conclusively evidenced by such person's execution, delivery, furnishing or filing of the applicable document. This power of attorney shall expressly revoke the power of attorney dated 8th day of December, 2015 in respect of the subject matter hereof, shall be valid from the date hereof and shall remain in full force and effect until either revoked in writing by the Company, or, in respect of any attorney-in-fact named herein, until such person ceases to be an employee of the Company or one of its affiliates. IN WITNESS WHEREOF, the undersigned has caused this power of attorney to be executed as of this 2nd day of January, 2019. BLACKROCK, INC. By:_ /s/ Daniel Waltcher Name: Daniel Waltcher Title: Deputy General Counsel
    Get the next $AEG alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $AEG

    DatePrice TargetRatingAnalyst
    5/7/2025Neutral → Outperform
    BNP Paribas Exane
    10/22/2024Neutral → Buy
    UBS
    5/28/2024Buy → Neutral
    UBS
    6/9/2023Hold → Buy
    HSBC Securities
    4/4/2023Neutral
    BofA Securities
    9/13/2022Hold → Buy
    Societe Generale
    7/5/2022Neutral → Underperform
    Exane BNP Paribas
    1/19/2022Underperform → Neutral
    BofA Securities
    More analyst ratings

    $AEG
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • AM Best Affirms Credit Ratings of Members of Aegon Ltd.'s U.S. Subsidiaries

      AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of "a+" (Excellent) of the U.S. life/health (L/H) subsidiaries of Aegon Ltd. (Bermuda) (NYSE:AEG). Aegon Ltd.'s U.S. L/H companies are Transamerica Life Insurance Company (Cedar Rapids, IA) and Transamerica Financial Life Insurance Company (Harrison, NY) and referred to collectively as Aegon USA Group (Aegon USA). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Aegon USA's balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management. AM

      1/28/25 5:31:00 PM ET
      $AEG
      Life Insurance
      Finance
    • Spruce Point Capital Management Announces Investment Opinion: Releases Report and Strong Sell Research Opinion on Aegon Ltd. (NYSE: AEG, Euronext: AGN)

      NOTE TO EDITORS: The Following is an Investment Opinion Issued by Spruce Point Capital Management Illustrates Why We Believe World Financial Group Operates an Aggressive Multi-Level-Marketing Business but Has Faced Allegations of Being a Pyramid Scheme Provides Evidence of FTC "Warning Signs" Such as Aggressive Claims in Their Recruiting and Sales Tactics Questions Management's Choice to Rely on Indexed-Universal Life Insurance Sales for Growth Expresses Concerns Over an Upstart Competitor Founded by One of World Financial Group's Former Top Producing Agents and the Impact It Could Have On World Financial Group's Recruiting Goals Estimates That a Sum-of-Parts Illustrative Valuatio

      12/16/24 7:30:00 AM ET
      $AEG
      Life Insurance
      Finance
    • AM Best Affirms Credit Ratings of Members of Aegon Ltd.'s U.S. Subsidiaries

      AM Best has affirmed the Financial Strength Rating of A (Excellent) and the Long-Term Issuer Credit Ratings of "a+" (Excellent) of the U.S. life/health (L/H) subsidiaries of Aegon Ltd. (Bermuda) (NYSE:AEG). Aegon Ltd.'s U.S. L/H companies are Transamerica Life Insurance Company (Cedar Rapids, IA) and Transamerica Financial Life Insurance Company (Harrison, NY) and referred to collectively as Aegon USA Group (Aegon USA). The outlook of these Credit Ratings (ratings) is stable. The ratings reflect Aegon USA's balance sheet strength, which AM Best assesses as very strong, as well as its strong operating performance, favorable business profile and appropriate enterprise risk management. Aeg

      12/20/23 2:29:00 PM ET
      $AEG
      Life Insurance
      Finance

    $AEG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Aegon N.V. upgraded by BNP Paribas Exane

      BNP Paribas Exane upgraded Aegon N.V. from Neutral to Outperform

      5/7/25 8:33:19 AM ET
      $AEG
      Life Insurance
      Finance
    • Aegon N.V. upgraded by UBS

      UBS upgraded Aegon N.V. from Neutral to Buy

      10/22/24 6:09:17 AM ET
      $AEG
      Life Insurance
      Finance
    • Aegon N.V. downgraded by UBS

      UBS downgraded Aegon N.V. from Buy to Neutral

      5/28/24 7:28:06 AM ET
      $AEG
      Life Insurance
      Finance

    $AEG
    SEC Filings

    See more
    • SEC Form 6-K filed by Aegon Ltd. New York Registry Shares

      6-K - AEGON LTD. (0000769218) (Filer)

      5/8/25 8:46:40 AM ET
      $AEG
      Life Insurance
      Finance
    • SEC Form 6-K filed by Aegon Ltd. New York Registry Shares

      6-K - AEGON LTD. (0000769218) (Filer)

      4/9/25 6:09:24 AM ET
      $AEG
      Life Insurance
      Finance
    • Amendment: SEC Form 20-F/A filed by Aegon Ltd. New York Registry Shares

      20-F/A - AEGON LTD. (0000769218) (Filer)

      4/1/25 7:14:19 AM ET
      $AEG
      Life Insurance
      Finance

    $AEG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G/A filed by Aegon Ltd. New York Registry Shares (Amendment)

      SC 13G/A - AEGON LTD. (0000769218) (Subject)

      2/9/24 12:59:27 PM ET
      $AEG
      Life Insurance
      Finance
    • SEC Form SC 13G/A filed by Aegon Ltd. New York Registry Shares (Amendment)

      SC 13G/A - AEGON LTD. (0000769218) (Subject)

      2/8/24 12:26:49 PM ET
      $AEG
      Life Insurance
      Finance
    • SEC Form SC 13D/A filed by Aegon Ltd. New York Registry Shares (Amendment)

      SC 13D/A - AEGON LTD. (0000769218) (Subject)

      12/29/23 6:43:57 AM ET
      $AEG
      Life Insurance
      Finance

    $AEG
    Financials

    Live finance-specific insights

    See more
    • Aegon completes share buyback program

      Aegon has completed the share buyback program announced on September 17, 2021, aimed at neutralizing the dilutive effect of the 2021 interim dividend paid in shares. The repurchased shares will be held as treasury shares and will be used to pay future dividends in shares. Between October 1, 2021 and October 26, 2021 common shares for an amount of EUR 96 million were repurchased. A total of 21,531,927 common shares were repurchased at an average price of EUR 4.46 per share. For further details visit our share buyback updates page at aegon.com. About Aegon Aegon's roots go back more than 175 years – to the first half of the nineteenth century. Since then, Aegon has grown into an internati

      10/27/21 2:00:00 AM ET
      $AEG
      Life Insurance
      Finance
    • Aegon to repurchase shares to neutralize impact of 2021 interim dividend paid in shares

      Aegon announced today that it will repurchase common shares for an amount of EUR 96 million to neutralize the dilutive effect of its 2021 interim dividend paid in shares. These shares will be held as treasury shares and will be used to pay future dividends in shares. Shareholders were given the opportunity to choose between receiving the 2021 interim dividend of EUR 0.08 per common share in cash or in shares. 58% of shareholders elected to receive the interim dividend in shares. The repurchase will commence on October 1, 2021 and is expected to be completed on or before October 26, 2021. Aegon will engage a third party to execute the transactions on its behalf. The common shares will be r

      9/17/21 2:00:00 AM ET
      $AEG
      Life Insurance
      Finance
    • Aegon completes share buyback program

      Aegon has completed the share buyback program to neutralize the dilutive effect of the 2020 final dividend paid in shares and certain share-based variable compensation plans for senior management, as announced on July 7, 2021. The repurchased shares will be held as treasury shares and will either be used to cover future dividends to be paid in shares or will be allocated to the participants of share-based variable compensation plans. Between July 8, 2021 and August 20, 2021 a total of 35,933,035 common shares were repurchased, at an average price of EUR 3.7013 per share. For further details, visit our share buyback updates page on aegon.com. About Aegon Aegon's roots go back more than

      8/23/21 2:00:00 AM ET
      $AEG
      Life Insurance
      Finance